NewsRx

Search our medical news database

DNA Research

Manufacturing authorization for DNA vaccine against infectious animal disease granted

Published in Vaccine Weekly, October 26th, 2005

Mologen AG (ISIN DE0006637200) has received the manufacturing authorization according to the German pharmaceutical act (Arzneimittelgesetz, AMG) for the agents of its MIDGE based DNA vaccine against an important infectious disease in animals.

Mologen successfully scaled up its production process following GMP (Good Manufacturing Practice) guidelines and finished the extension process for the Berlin production sites, which had been started in 2004.

The agents, which are produced in compliance with GMP standards, are permitted to be used in and sold for clinical studies in the future.

The increased production capacities are able to...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook